Literature DB >> 25527208

Trends in the dispensation of antidepressant drugs over the past decade (2000-2010) in Andalusia, Spain.

M C González-López1, C M Rodríguez-López, T Parrón-Carreño, J D Luna, E Del Pozo.   

Abstract

PURPOSE: To study antidepressant drug dispensation in the Spanish region of Andalusia and in the Almeria Health Area (AHA) over the past decade, analyzing the variability, trends, and influential factors.
METHODS: We conducted an observational ecological study of antidepressant drug dispensation between 2000 and 2010 in Andalusia. Dispensation was measured as Defined Daily Dose (DDD) per 1,000 inhabitants per day. A multilevel analysis (STATA 11.1) was performed to determine the variability among the basic health zones (BHZs) (2004-2010) and influential factors.
RESULTS: Between 2000 and 2010, the total dispensation of antidepressant drugs increased by more than 100 % in Andalusia and in the AHA. This increase was primarily caused by the greater dispensation of selective serotonin reuptake inhibitors (ATC-N06AB) and other antidepressants (ATC-N06AX). Multilevel analysis revealed a wide variability in the levels and trends of antidepressant dispensation among BHZs. Urbanicity and the percentage of immigrants in the BHZ were negatively associated with their dispensation, which was positively influenced by a higher proportion of women and over 65-year-olds in the population.
CONCLUSIONS: The elevated dispensation of several groups of antidepressant drugs in this study population indicates the need for health policies to rationalize their use. Further research is required into the differences in antidepressant dispensations between immigrant and native populations and the implications for public health policies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527208     DOI: 10.1007/s00127-014-0995-9

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  38 in total

1.  [Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study].

Authors:  Josep M Haro; Concepció Palacín; Gemma Vilagut; Montse Martínez; Mariola Bernal; Inma Luque; Miquel Codony; Montse Dolz; Jordi Alonso
Journal:  Med Clin (Barc)       Date:  2006-04-01       Impact factor: 1.725

2.  Factors influencing variation in prescribing of antidepressants by general practices in Scotland.

Authors:  Jill Morrison; Mary-Jane Anderson; Matt Sutton; Rosalia Munoz-Arroyo; Sara McDonald; Margaret Maxwell; Andrew Power; Michael Smith; Philip Wilson
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

Review 3.  Can effects of antidepressants in patients with mild depression be considered as clinically significant?

Authors:  Ulrich Hegerl; Antje-Kathrin Allgaier; Verena Henkel; Roland Mergl
Journal:  J Affect Disord       Date:  2011-06-08       Impact factor: 4.839

4.  Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care plan.

Authors:  Jasmina I Ivanova; Catherine Bienfait-Beuzon; Howard G Birnbaum; Cristina Connolly; Srinivas Emani; Michael Sheehy
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

5.  Antidepressant use in the absence of common mental disorders in the general population.

Authors:  Jina Pagura; Laurence Y Katz; Ramin Mojtabai; Benjamin G Druss; Brian Cox; Jitender Sareen
Journal:  J Clin Psychiatry       Date:  2011-01-25       Impact factor: 4.384

Review 6.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

Authors:  Andrea Cipriani; Toshiaki A Furukawa; Georgia Salanti; John R Geddes; Julian Pt Higgins; Rachel Churchill; Norio Watanabe; Atsuo Nakagawa; Ichiro M Omori; Hugh McGuire; Michele Tansella; Corrado Barbui
Journal:  Lancet       Date:  2009-02-28       Impact factor: 79.321

7.  Epidemiology of major depressive episode in a southern European country: results from the ESEMeD-Spain project.

Authors:  Andrea Gabilondo; Sonia Rojas-Farreras; Gemma Vilagut; Josep M Haro; Ana Fernández; Alejandra Pinto-Meza; Jordi Alonso
Journal:  J Affect Disord       Date:  2010-01       Impact factor: 4.839

8.  General practitioners' choices and their determinants when starting treatment for major depression: a cross sectional, randomized case-vignette survey.

Authors:  Hélène Dumesnil; Sébastien Cortaredona; Hélène Verdoux; Rémy Sebbah; Alain Paraponaris; Pierre Verger
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

9.  Depression prevalence and primary care among vulnerable patients at a free outpatient clinic in Paris, France, in 2010: results of a cross-sectional survey.

Authors:  Claire Rondet; Philippe Cornet; Bacha Kaoutar; Jacques Lebas; Pierre Chauvin
Journal:  BMC Fam Pract       Date:  2013-10-11       Impact factor: 2.497

10.  Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics.

Authors:  Liset van Dijk; Eibert R Heerdink; Dinesh Somai; Sandra van Dulmen; Emmy M Sluijs; Denise T de Ridder; Anna M G F Griens; Jozien M Bensing
Journal:  BMC Health Serv Res       Date:  2007-04-10       Impact factor: 2.655

View more
  5 in total

1.  Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017.

Authors:  Johanna Seifert; Fabienne Führmann; Marcel Sieberer; Waldemar Greil; Matthias A Reinhard; Rolf R Engel; Xueqiong Bernegger; Stefan Bleich; Susanne Stübner; Eckart Rüther; Sermin Toto; Renate Grohmann
Journal:  J Neural Transm (Vienna)       Date:  2021-05-11       Impact factor: 3.575

2.  Influences on antidepressant prescribing trends in the UK: 1995-2011.

Authors:  Becky Mars; Jon Heron; David Kessler; Neil M Davies; Richard M Martin; Kyla H Thomas; David Gunnell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-11-24       Impact factor: 4.328

3.  Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data.

Authors:  Elisa Haller; Birgit Watzke; Eva Blozik; Thomas Rosemann; Oliver Reich; Carola A Huber; Markus Wolf
Journal:  BMC Psychiatry       Date:  2019-06-24       Impact factor: 3.630

4.  Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study.

Authors:  Carlotta Lunghi; Ippazio Cosimo Antonazzo; Sofia Burato; Emanuel Raschi; Violetta Zoffoli; Emanuele Forcesi; Elisa Sangiorgi; Marco Menchetti; Pasquale Roberge; Elisabetta Poluzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-07       Impact factor: 2.570

5.  Trends in the utilization of psychotropic medications in China from 2018 to 2021.

Authors:  Xinyan Zhang; Xiaowen Hu; Yuxuan Zhao; Christine Y Lu; Xiaoyan Nie; Luwen Shi
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.